Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, Ingmar, Hsu, Christine C., Troeger, Juliane S., Huebener, Peter, Mu, Xueru, Dapito, Dianne H., Pradere, Jean-Philippe, Schwabe, Robert F.·2013·Nature Communications

Cited by (1,001)

Items 701–800 of 1,001

  1. The forkhead box F1 transcription factor inhibits collagen deposition and accumulation of myofibroblasts during liver fibrosis
    Hannah M. Flood, Craig Bolte, Nupur Dasgupta, Akanksha Sharma, Yufang Zhang, Chandrashekhar R. Gandhi, Tanya V. Kalin, Vladimir V. Kalinichenko · 2019 · Biology Open
  2. iRhom2 inhibits bile duct obstruction–induced liver fibrosis
    Balamurugan Sundaram, Kristina Behnke, Andrea Belancic, Mazin A. Al-Salihi, Yasser Thabet, Robin Polz, Rossella Pellegrino, Yuan Zhuang, Prashant V. Shinde, Haifeng C. Xu et al. · 2019 · Science Signaling
  3. Total phenolic extract of Euscaphis konishii hayata Pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice
    Wei Huang, Yi Zheng, He Feng, Lin Ni, Yi-fang Ruan, Xiaoxing Zou, Min Ye, Shuangquan Zou · 2020 · Biomedicine & Pharmacotherapy
  4. Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?
    Andre J. Jeyarajan, Raymond T. Chung · 2020 · The Journal of Infectious Diseases
  5. Portal Fibroblasts in Biliary Fibrosis
    Rebecca G. Wells · 2014 · Current Pathobiology Reports
  6. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway
    Xuanfei Li, Hao Chen, Zhujun Yi, Liu Yanming, Gong Jianping · 2017 · Oncotarget
  7. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C‐infected persons: Results from ERCHIVES
    J. Y. Chen, Yanjie Ren, P. Yan, Morgan E. Belina, Raymond T. Chung, Adeel Ajwad Butt · 2018 · Journal of Viral Hepatitis
  8. Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells
    Canesin, Giacomo, Feldbrügge, Linda, Wei, Guangyan, Janovicova, Lubica, Janikova, Monika, Csizmadia, Eva, Ariffin, Juliana, Hedblom, Andreas, Herbert, Zachary T., Robson, Simon C. et al. · 2022 · iScience
  9. Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis
    Shearn, C.T., Orlicky, D.J., Saba, L.M., Shearn, A.H., Petersen, Dennis R. · 2015 · Free Radical Biology and Medicine
  10. Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis Efficacy
    Zhaoxia Cheng, Fenfen Li, Yunkai Qie, Jingyi Sun, Yazhou Wang, Ying Zhao, Guangjun Nie · 2024 · Nano Letters
  11. AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis
    Yuan Guan, Lu Cui, Jakkapong Inchai, Zhuoqing Fang, Jacky Law, Alberto Alonzo Garcia Brito, Annalisa Pawlosky, Juraj Gottweis, Alexander Daryin, Anatoly Myaskovsky et al. · 2025 · Advanced Science
  12. Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
    Keiko Iwaisako, Kojiro Taura, Yukinori Koyama, Kenji Takemoto, Masataka Asagiri · 2014 · Current Pathobiology Reports
  13. Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease
    Rebecca E. Bignold, Bushra Shammout, Jessica E. Rowley, Mariaelena Repici, John Simms, Jill R. Johnson · 2022 · Respiratory Research
  14. Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function
    Kushan Chowdhury, Menghao Huang, Hyeong-Geug Kim, Xiaocheng Charlie Dong · 2022 · The FASEB Journal
  15. The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis
    Jing-Bei Zhang, Hongliu Jin, Xiao‐Ying Feng, Senling Feng, Wenting Zhu, Hong-Mei Nan, Zhongwen Yuan · 2022 · Frontiers in Pharmacology
  16. Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells
    Yuzo Koda, Nobuhiro Nakamoto, Takanori Kanai∥ · 2022 · Seminars in Liver Disease
  17. Multiple Facets of Cellular Homeostasis and Regeneration of the Mammalian Liver
    Stacey S. Huppert, Robert E. Schwartz · 2022 · Annual Review of Physiology
  18. Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
    Taylor J. Kelty, Ryan J. Dashek, William David Arnold, R. Scott Rector · 2023 · Seminars in Liver Disease
  19. Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose
    Hung‐Chun Tung, Jong-Won Kim, Junjie Zhu, Sihan Li, Jiong Yan, Qing Liu, Imhoi Koo, С. А. Кошкин, Fuhua Hao, Guo Gan Zhong et al. · 2024 · Science Translational Medicine
  20. Adrenic acid: A promising biomarker and therapeutic target (Review)
    Ze Wang, Haoyang Gao, Xiaotong Ma, Danlin Zhu, Linlin Zhao, Weihua Xiao · 2024 · International Journal of Molecular Medicine
  21. Immunohistochemical characterization of myofibroblasts appearing in isoproterenol-induced rat myocardial fibrosis
    Masaaki KOGA, Mizuki Kuramochi, Mohammad Rabiul Karim, Takeshi Izawa, Mitsuru Kuwamura, Jyoji Yamate · 2018 · Journal of Veterinary Medical Science
  22. Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice
    Felix Hempel, M Roderfeld, Rajkumar Savai, Akylbek S. Sydykov, Karuna Irungbam, RALPH THEO SCHERMULY, Robert Voswinckel, Kernt Köhler, Yuri Churin, Ladislau Kiss et al. · 2019 · Cells
  23. Bayesian correlation is a robust gene similarity measure for single-cell RNA-seq data
    Daniel Sánchez‐Taltavull, Theodore J. Perkins, Noëlle Dommann, Nicolas Mélin, Adrian Keogh, Daniel Candinas, Deborah Stroka, Guido Beldi · 2020 · NAR Genomics and Bioinformatics
  24. A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo
    Saimir Luli, Daniela Di Paolo, Patrizia Perri, Chiara Brignole, Stephen J. Hill, Helen J. Brown, Jack Leslie, Helen L. Marshall, Matthew C. Wright, Derek A. Mann et al. · 2016 · Journal of Hepatology
  25. CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-β, Wnt and STAT3 signaling pathways
    In-Yu Lin, Yi‐Shiou Chiou, Li-Ching Wu, Chen-Yu Tsai, Chiung-Tong Chen, Wu‐Chang Chuang, Ming-Chung Lee, Ching-Che Lin, Ting-Ting Lin, Ssu‐Ching Chen et al. · 2018 · Journal of Food and Drug Analysis
  26. What gastroenterologists and hepatologists should know about organoids in 2019
    Claudia Günther, Teresa Brevini, Fotios Sampaziotis, Markus Friedrich Neurath · 2019 · Digestive and Liver Disease
  27. CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway
    Junfu Fan, Gaozan Tong, Xixi Chen, Santie Li, Ying Fang Yu, Shunan Zhu, Kunxuan Zhu, Zijing Hu, Yonggan Dong, Rui Chen et al. · 2022 · British Journal of Pharmacology
  28. Culture Model of Rat Portal Myofibroblasts
    Haquima El Mourabit, Emilien J. Loeuillard, Sara Lemoinne, Axelle Cadoret, Chantal Housset · 2016 · Frontiers in Physiology
  29. Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model
    Yifan Tong, Ning Meng, Miao-Qin Chen, Hanning Ying, Ming Xu, Billy Lu, Junjie Hong, Yifan Wang, Xiujun Cai · 2018 · World Journal of Gastroenterology
  30. Sox9EGFP Defines Biliary Epithelial Heterogeneity Downstream of Yap Activity
    Deepthi Y. Tulasi, Diego Martinez Castaneda, Kortney Wager, Connor B. Hogan, Karel P. Alcedo, Jesse R. Raab, Adam D. Gracz · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  31. Hepatic stellate cell activation by TGFβ induces hedgehog signaling and endoplasmic reticulum stress simultaneously
    Roya Solhi, Abbas Sahebghadam Lotfi, Majid Lotfinia, Zahra Farzaneh, Abbas Piryaei, Mustapha Najimi, Massoud Vosough · 2022 · Toxicology in Vitro
  32. Coprinus comatus polysaccharides ameliorated carbon tetrachloride-induced liver fibrosis through modulating inflammation and apoptosis
    Huajie Zhao, Duan Li, Min� Li, Liang Liu, Baoguo Deng, Le Jia, Fan Yang · 2022 · Food & Function
  33. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts
    Weicong Chen, Xuemei Yang, Jialing Sun, Yuyao Chen, Wenting Zhao, Chunyu He, Haiyan An, Jie Pang, Wei Xu, Bin Wen et al. · 2022 · Journal of Ethnopharmacology
  34. Autophagy Inhibitor Chloroquine Downmodulates Hepatic Stellate Cell Activation and Liver Damage in Bile-Duct-Ligated Mice
    Trinh Van Le, Hong-Thuy Phan-Thi, My-Xuan Huynh-Thi, Thanh Minh Dang, Ai‐Xuan Holterman, Gabriele Grassi, Nguyen Luu Thao Uyen, Nhung Hai Truong · 2023 · Cells
  35. Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis
    Sonal Sinha, Satoka Aizawa, Yasuhiro Nakano, Alexander Rialdi, Hye Yeon Choi, Rajan Shrestha, Stephanie Q. Pan, Yibu Chen, Meng Li, Audrey Kapelanski‐Lamoureux et al. · 2023 · Nature Communications
  36. “The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the Liver
    Alexandra Bogomolova, Asha Balakrishnan, Michael Ott, Amar Deep Sharma · 2024 · Cellular and Molecular Gastroenterology and Hepatology
  37. Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
    Harrison T. Muturi, Hilda E. Ghadieh, Suman Asalla, Sumona Ghosh Lester, Getachew Debas Belew, Sobia Zaidi, Raziyeh Abdolahipour, Abhishek P Shrestha, Agnes O Portuphy, Hannah L. Stankus et al. · 2024 · Molecular Metabolism
  38. Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis
    Ross Dobie, Neil Cowan Henderson · 2016 · F1000Research
  39. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C
    Joanna Górka-Dynysiewicz, Monika Pazgan−Simon, Jolanta Zuwała−Jagiełło · 2019 · BioMed Research International
  40. The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure
    Xiangying Zhang, Peiling Dong, Lin Xu, Yuan Tian, Huayin Sun, Hongbo Shi, Zhongping Duan, Liyan Chen, Feng Zhang Ren · 2019 · BMC Gastroenterology
  41. Astragaloside IV attenuates renal fibrosis through repressing epithelial-to-mesenchymal transition by inhibiting microRNA-192 expression: in vivo and in vitro studies.
    Yaochen Cao, Li Zhang, Yu Wang, Qing‐Chun Fan, Yakun Cong · 2019 · Europe PMC (PubMed Central)
  42. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis
    Xia Xie, Chengyun Dou, Yu Zhou, Quan Zhou, Haibo Tang · 2020 · Digestive Diseases and Sciences
  43. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis
    Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa et al. · 2021 · Journal of Clinical Medicine
  44. The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
    Hiroaki Fuji, Grant Miller, Takahiro Nishio, Yukinori Koyama, Kevin Lam, Vivian Zhang, Rohit Seth Loomba, David A. Brenner, Tatiana Kisseleva · 2021 · Frontiers in Molecular Biosciences
  45. Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model
    Mitsugu Watanabe, Hirotoshi Fuda, Hiroaki Okabe, Sae Joko, Yusuke Miura, Shu‐Ping Hui, Yimin, Naohiro Hamaoka, Emiko Miki, Hitoshi Chiba · 2015 · Journal of Functional Foods
  46. GDF2 and BMP10 coordinate liver cellular crosstalk to maintain liver health
    Zhao, Dianyuan, Huang, Ziwei, Li, Xiaoyu, Wang, Huan, Hou, Qingwei, Wang, Yuyao, Yan, Fang, Yang, Wenting, Liu, Di, Yi, Shaoqiong et al. · 2024 · eLife
  47. Mechanisms of Metal-Induced Hepatic Inflammation
    Nivetha Subramaniam, Koren Kathleen Mann · 2024 · Current Environmental Health Reports
  48. PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma
    Yanhua Du, Yizhou Zhao, Ju‐Dong Li, Jiaxin Wang, Shenglan You, Yao Zhang, Li Zhang, Jihong Yang, Hamid Alinejad‐Rokny, Shujie Cheng et al. · 2025 · Advanced Science
  49. Targeting ketone body metabolism to treat fatty liver disease
    Sora Kwon, Reshani Jeyaratnam, Kyoung-Han Kim · 2024 · Journal of Pharmacy & Pharmaceutical Sciences
  50. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1
    Rajani Kandhi, Diwakar Bobbala, Mehdi Yeganeh, Marian Mayhue, Alfredo Menéndez, Subburaj Ilangumaran · 2015 · Cytokine
  51. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice
    Cheri L. Lamb, Giovan N. Cholico, Xinzhu Pu, Gerald D. Hagler, Ken Cornell, Kristen A. Mitchell · 2016 · Toxicology and Applied Pharmacology
  52. Stellate Cells and Hepatic Fibrosis
    Daisuke Hasegawa, Michael C. Wallace, Scott L. Friedman · 2015 · Elsevier eBooks
  53. Inflammatory networks cultivate cancer cell metastasis to the liver
    Jae Woo Lee, Gregory Lawrence Beatty · 2020 · Cell Cycle
  54. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis
    Mishghan Zehra, James C Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi · 2020 · International Journal of Molecular Sciences
  55. Optimization of the isolation procedure and culturing conditions for hepatic stellate cells obtained from mouse
    Thanh Minh Dang, Trinh Van Le, Huy Quang Do, Van Thuan Nguyen, Ai‐Xuan Holterman, Loan Tung Thi Dang, Nhan Lu-Chinh Phan, Phuc Van Pham, Hoàng Nghĩa Sơn, Lê Thành Long et al. · 2020 · Bioscience Reports
  56. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice
    Daifei Shen, Cheng He, Bozhi Cai, Wen-feng Cai, Bin Wang, Qing Zhu, Yue-bin Wu, Man Liu, Runji Chen, Fenfei Gao et al. · 2021 · Acta Pharmacologica Sinica
  57. The Liver and the Hepatic Immune Response in Trypanosoma cruzi Infection, a Historical and Updated View
    Natália Vacani-Martins, Marcelo Meuser-Batista, Carina de Lima Pereira dos Santos, Alejandro Marcel Hasslocher‐Moreno, Andrea Henriques‐Pons · 2021 · Pathogens
  58. Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1
    Zhenyu Xu, Bo He, Yongfang Jiang, Min Zhang, Yi Tian, Ning Zhou, Yanwen Zhou, Mengxuan Chen, Min Tang, Jiashi Gao et al. · 2022 · International Immunopharmacology
  59. Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity
    Frederik T. Larsen, Daniel Hansen, Mike Krogh Terkelsen, Sofie Marchsteiner Bendixen, Fabio Avolio, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen, Lea Ladegaard Grønkjær, Birgitte Gade Jacobsen, Ellen Gammelmark et al. · 2022 · JHEP Reports
  60. Aryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis
    Cheri L. Lamb, Giovan N. Cholico, Daniel E. Perkins, Michael T. Fewkes, Julia Thom Oxford, Trevor J. Lujan, Erica E. Morrill, Kristen A. Mitchell · 2016 · BioMed Research International
  61. Functionality based method for simultaneous isolation of rodent hepatic sinusoidal cells
    Leslie Stradiot, Stefaan Verhulst, Tiffany Roosens, Cristina Ionica Øie, Iván M. Moya, Georg A. Halder, Inge Mannaerts, Leo A. van Grunsven · 2017 · Biomaterials
  62. Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver
    Mengying Hu, Leaf Huang · 2018 · Advanced Functional Materials
  63. Expression of neuropeptide Y is increased in an activated human HSC cell line
    Wufei Dai, Yang Liu, Yali Zhang, Yufeng Sun, Changjiang Sun, Yu Zhang, Xiufang Lv · 2019 · Scientific Reports
  64. Aryl Hydrocarbon Receptor Alleviates Hepatic Fibrosis by Inducing Hepatic Stellate Cell Ferroptosis
    Shenghui Liu · 2024 · Journal of Cellular and Molecular Medicine
  65. Organ fibrosis: beyond collagen I expression. Fibroblast phenotype and basement membrane proteins
    Rachel M. Biggs, Amy D. Bradshaw · 2025 · American Journal of Physiology-Cell Physiology
  66. Sirtuins and Hypoxia in EMT Control
    Michele Aventaggiato, Federica Barreca, Luigi Sansone, Laura Pellegrini, Matteo Antonio Russo, Marco Cordani, Marco Tafani · 2022 · Pharmaceuticals
  67. A High Hepatic Uptake of Conjugated Bile Acids Promotes Colorectal Cancer—Associated Liver Metastasis
    Zongmei Zheng, Jiao Wei, Xinxin Hou, Fengjing Jia, Zhaozhou Zhang, Haidong Guo, Fuwen Yuan, Feng He, Zunji Ke, Yan Wang et al. · 2022 · Cells
  68. HOXC8/TGF-β1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling
    Ning Zhang, Fang Guo, Yuanyuan Song · 2023 · Biochemical and Biophysical Research Communications
  69. FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts
    Liankang Sun, Yue Li, Hao Wang, Xuelian Xiao, Xuenan Luo, Ruida Yang, Jinyan Li, Yifei Ma, Qingguang Liu, Kangsheng Tu et al. · 2023 · International Journal of Biological Sciences
  70. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma
    Hai-Chen Wang, Wen-Xuan Yin, Meng Jiang, Jiayi Han, Xingwang Kuai, Rui Sun, Yu-Feng Sun, Juling Ji · 2023 · World Journal of Gastroenterology
  71. The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
    Mengchao Yan, Ye Xie, Jia Yao, Xun� Li · 2023 · International Journal of Molecular Sciences
  72. Serological Exosome Metabolic Biopsy of Hepatocellular Carcinoma via Designed Core–Shell Nanoparticles
    Chenyu Yang, Haolin Chen, Chunhui Deng, Nianrong Sun · 2024 · Analytical Chemistry
  73. Crosstalk in extrahepatic and hepatic system in NAFLD / NASH
    Yiliang Duan, Yan Zhu Yang, Shuqiang Zhao, Yuesong Bai, Wenbing Yao, Xiangdong Gao, Jun Yin · 2024 · Liver International
  74. Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
    Na Young Lee, Myeung Gi Choi, Eui Jin Lee, Ja Hyun Koo · 2024 · Archives of Pharmacal Research
  75. Hepatic stellate cells regulate liver fatty acid utilization via plasmalemma vesicle-associated protein
    Daniel Hansen, Jasmin E.R. Jensen, Christian A.T. Andersen, Peter R. Jakobsgaard, Jesper Foged Havelund, Line Lauritsen, Samuel Coelho Mandacaru, Majken Storm Siersbæk, Oliver L Shackleton, Hiroshi Inoue et al. · 2025 · Cell Metabolism
  76. Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH
    Colin T. Shearn, Laura M. Saba, James R. Roede, David J. Orlicky, Alisabeth H. Shearn, Dennis R. Petersen · 2017 · Free Radical Biology and Medicine
  77. A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells
    Daniel Benten, Johannes Kluwe, Jan W. Wirth, Nina D. Thiele, Antonia Follenzi, Kuldeep K. Bhargava, Christopher J. Palestro, Michael Koepke, Reni Tjandra, Tassilo Volz et al. · 2018 · Laboratory Investigation
  78. Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities
    Jorge Simón, Teresa C. Delgado, Luis Alfonso Martínez‐Cruz, Maria Luz Martínez‐Chantar · 2021 · Biomedicines
  79. Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway
    Yong Joo Park, Mi Seon Jeon, Seulah Lee, Jung Kyu Kim, Tae Su Jang, Kyu Hyuck Chung, Ki Hyun Kim · 2021 · Bioorganic & Medicinal Chemistry Letters
  80. A conserved pathway of transdifferentiation in murine Kupffer cells
    Xinyu Li, Nicole Hollingshead, Sarah Lampert, Camtu D. Truong, Wanyu Li, Junqi Niu, Ian Nicholas Crispe, Radika Soysa · 2021 · European Journal of Immunology
  81. Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway
    Ikuo Nakamura, Faizal Z. Asumda, Catherine D. Moser, Yoo Na Kang, Jinping Lai, Lewis Rowland Roberts · 2021 · Cancers
  82. CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway
    Zhenni Liu, Xue Wu, Qi Wang, Zixuan Li, Xueqi Liu, Xiaodong Sheng, Hong Zhu, Mengda Zhang, Junrui Xu, Xiaowen Feng et al. · 2022 · Frontiers in Pharmacology
  83. Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
    Samim Ali Mondal, Shivani N. Mann, Carl van der Linden, Roshini Sathiaseelan, Maria Kamal, Snehasis Das, Matthew P. Bubak, Sreemathi Logan, Benjamin F. Miller, Michael B. Stout · 2023 · Scientific Reports
  84. Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection
    Isabelle Nel, Olivier Lucar, Caroline Petitdemange, Vivien Béziat, Martine Lapalus, Pierre Bédossa, Patrice Debré, Tarik Asselah, Patrick Marcellin, Vincent Vieillard · 2016 · Medicine
  85. RNA Binding Proteins Control Transdifferentiation of Hepatic Stellate Cells into Myofibroblasts
    Sihyung Wang, Youngmi Jung, Jeongeun Hyun, Matthew B. Friedersdorf, Seh‐Hoon Oh, Jieun Kim, Richard T. Premont, Jack D. Keene, Anna Mae Diehl · 2018 · Cellular Physiology and Biochemistry
  86. Twelve-year experience with the 19 mm Carpentier-Edwards pericardial aortic valve.
    H Nakajima, Michel R. Aupart, Paul H Neville, A Sirinelli, Y Meurisse, Michel A. Marchand · 1998 · PubMed
  87. Pericytes in tissue fibrosis
    Izabela Tuleta, Nikolaos Georgios Frangogiannis · 2025 · American Journal of Physiology-Cell Physiology
  88. Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential
    Wahyu Widowati, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Aris Muhamad Nurjamil, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Rizal Azis, Elham Rismani, Massoud Vosough · 2026 · Journal of Immunology Research
  89. Extracts of Periplaneta americana alleviate hepatic fibrosis by affecting hepatic TGF-β and NF-κB expression in rats with pig serum-induced liver fibrosis
    Dingchun Li, Dehong Ma, Ye Liu, Lihui Liu, Yihui Chen, Huaie Liu, Lu Zhang, Jie Lu, Kexuan Chen, Jing You et al. · 2022 · Folia Histochemica et Cytobiologica
  90. Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells
    Wenyang Li, Jennifer Y. Chen, Cheng Sun, Robert P. Sparks, Lorena Pantano, Raza‐Ur Rahman, Sean P. Moran, Joshua V. Pondick, Rory Kirchner, David Wrobel et al. · 2022 · eLife
  91. In Situ Regulation and Mechanisms of 3D Matrix Stiffness on the Activation and Reversion of Hepatic Stellate Cells
    Guobao Chen, Yaxin Deng, Bin Xia, Yonggang Lv · 2022 · Advanced Healthcare Materials
  92. Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
    Weiwei He, Caoxin Huang, Xiulin Shi, Menghua Wu, Han Li, Qiuhong Liu, Xiaofang Zhang, Yan Zhao, Xuejun Li · 2022 · Endocrine Connections
  93. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
    Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Louise Reeves, Robert Bart Takkenberg, Joost P.H. Drenth, Maarten E. Tushuizen, Adriaan Georgius Holleboom · 2023 · Cancers
  94. The origins, roles and therapies of cancer associated fibroblast in liver cancer
    Natasha Zulaziz, San Jiun Chai, Kue Peng Lim · 2023 · Frontiers in Oncology
  95. Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis
    Jiang, Chenhao, Chen, Huaxin, Kang, Yinqian, He, Xinyi, Huang, Jianyang, Lu, Tongyu, Sui, Xin, Chen, Haitian, Xiao, Jiaqi, Zhang, Jiebin et al. · 2023 · Cell Death Discovery
  96. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
    Li Xie, Hui Chen, Li Zhang, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yuli Wang, Yue Ma, Ya-Jun Yan, Jia Ding et al. · 2024 · Clinical and Molecular Hepatology
  97. Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
    An-Na Moon, François Briand, Natália Martins Breyner, Dong Keun Song, Martin Rønn Madsen, Hongbin Kim, Keonwoo Choi, Yoonsuk Lee, Wan Namkung · 2024 · Biomedicine & Pharmacotherapy
  98. Identification of a Novel Bone Marrow Cell-Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice
    Takayo Yanagawa, Hideaki Sumiyoshi, Kiyoshi Higashi, Sachie Nakao, Reiichi Higashiyama, Hiroshi Fukumitsu, Kaori Minakawa, Yosuke Chiba, Yuhei Suzuki, Kayo Sumida et al. · 2018 · Stem Cells
  99. Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway
    Adnan Naim, Mirza S. Baig · 2020 · Molecular and Cellular Biochemistry
  100. Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
    María Teresa Borrello, Derek A. Mann · 2022 · British Journal of Pharmacology